Oropharyngeal Candidiasis: A review of Current Intervention Strategies

C. Emery
{"title":"Oropharyngeal Candidiasis: A review of Current Intervention Strategies","authors":"C. Emery","doi":"10.1017/S1467115804000318","DOIUrl":null,"url":null,"abstract":"Summary This article sets out to review recent research studies pertaining to the drug treatment of oropharyngeal candidiasis in infants. The main aims of treatment programmes are to resolve signs and symptoms of the infection; and minimise drug induced resistance, with minimal adverse side effects. A search for clinical evidence using Medline, Nursing Index and Embase between 1995 and 2003, produces no systemic reviews, no placebo controlled trials only three random control trials for the treatment of oropharyngeal candidiasis in infants. Three independent randomised control trials with samples of infants with oropharyngeal candidiasis (who were not immuno-compromised), compare the three main drug treatments of choice for infants, i.e. miconazole gel, clotrimazole (nystatin) suspension, and fluconazole suspension. The randomised trial of these infants found that miconazole gel had a significantly higher cure rate compared with nystatin suspension. At day 12 of the trial there was a 99% cure rate with the use of miconazole gel (25 mg QDS) compared to only a cure rate of 54% with nystatin suspension (100 000 IU QDS) (P>","PeriodicalId":117012,"journal":{"name":"Nurse Prescriber","volume":"16 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2004-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nurse Prescriber","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1017/S1467115804000318","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Summary This article sets out to review recent research studies pertaining to the drug treatment of oropharyngeal candidiasis in infants. The main aims of treatment programmes are to resolve signs and symptoms of the infection; and minimise drug induced resistance, with minimal adverse side effects. A search for clinical evidence using Medline, Nursing Index and Embase between 1995 and 2003, produces no systemic reviews, no placebo controlled trials only three random control trials for the treatment of oropharyngeal candidiasis in infants. Three independent randomised control trials with samples of infants with oropharyngeal candidiasis (who were not immuno-compromised), compare the three main drug treatments of choice for infants, i.e. miconazole gel, clotrimazole (nystatin) suspension, and fluconazole suspension. The randomised trial of these infants found that miconazole gel had a significantly higher cure rate compared with nystatin suspension. At day 12 of the trial there was a 99% cure rate with the use of miconazole gel (25 mg QDS) compared to only a cure rate of 54% with nystatin suspension (100 000 IU QDS) (P>
口咽念珠菌病:当前干预策略综述
本文旨在回顾有关婴幼儿口咽念珠菌病药物治疗的最新研究。治疗方案的主要目的是消除感染的体征和症状;最大限度地减少药物引起的耐药性,并将不良副作用降到最低。使用Medline、Nursing Index和Embase检索1995年至2003年间的临床证据,没有发现系统评价,也没有安慰剂对照试验,只有三个治疗婴儿口咽念珠菌病的随机对照试验。三项独立随机对照试验对患有口咽念珠菌病的婴儿(未出现免疫功能低下)进行了比较,比较了婴儿可选择的三种主要药物治疗,即咪康唑凝胶、克霉唑(制霉菌素)混悬液和氟康唑混悬液。这些婴儿的随机试验发现,咪康唑凝胶的治愈率明显高于制霉菌素悬浮液。在试验的第12天,使用咪康唑凝胶(25 mg QDS)的治愈率为99%,而制霉菌素混悬液(10万IU QDS)的治愈率仅为54% (P>
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书